NO20004550L - Enzyminhibitorer - Google Patents

Enzyminhibitorer

Info

Publication number
NO20004550L
NO20004550L NO20004550A NO20004550A NO20004550L NO 20004550 L NO20004550 L NO 20004550L NO 20004550 A NO20004550 A NO 20004550A NO 20004550 A NO20004550 A NO 20004550A NO 20004550 L NO20004550 L NO 20004550L
Authority
NO
Norway
Prior art keywords
compounds
hair
health
skin
enzyme inhibitors
Prior art date
Application number
NO20004550A
Other languages
English (en)
Other versions
NO20004550D0 (no
Inventor
John Mcmillan Mciver
Todd Laurence Underiner
Timothy Bates
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO20004550D0 publication Critical patent/NO20004550D0/no
Publication of NO20004550L publication Critical patent/NO20004550L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48—Polymers modified by chemical after-treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/77—Polymers containing oxygen of oxiranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/86—Polyethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/14—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/18—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/331—Polymers modified by chemical after-treatment with organic compounds containing oxygen
    • C08G65/332—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof
    • C08G65/3324—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic
    • C08G65/3326—Polymers modified by chemical after-treatment with organic compounds containing oxygen containing carboxyl groups, or halides, or esters thereof cyclic aromatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyethers (AREA)

Abstract

Foreliggende oppfinnelse vedrører forbindelser, preparater og fremgangsmåter som er anvendbare for forebygging og behandling av ugunstige tilstander i forbindelse med helse, hud, hår og for orale tilstander. Forbindelsene, preparatene og fremgangsmåtene passer også i stor grad for anvendelse innen helse, hud, hår, ved orale anvendelser, innen skjønn- hetspleie og innen personlig pleie. Spesielt vedrører den foreliggende oppfinnelse forbindelser som har strukturen (I): og tautomerer, aksepterbare salter og biohydrolyserbare amider, estere og imider derav, hvor A, Q, n, P, Llr L2, L3, i Z, X, Bj_ og B2 er som definert heri.
NO20004550A 1998-03-12 2000-09-12 Enzyminhibitorer NO20004550L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/041,196 US6066673A (en) 1998-03-12 1998-03-12 Enzyme inhibitors
PCT/US1999/005314 WO1999046316A2 (en) 1998-03-12 1999-03-11 Enzyme inhibitors

Publications (2)

Publication Number Publication Date
NO20004550D0 NO20004550D0 (no) 2000-09-12
NO20004550L true NO20004550L (no) 2000-11-10

Family

ID=21915262

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20004550A NO20004550L (no) 1998-03-12 2000-09-12 Enzyminhibitorer

Country Status (18)

Country Link
US (2) US6066673A (no)
EP (1) EP1062264A2 (no)
JP (1) JP2002506099A (no)
KR (1) KR20010041860A (no)
CN (1) CN1300303A (no)
AU (1) AU2903799A (no)
BR (1) BR9909248A (no)
CA (1) CA2323496A1 (no)
CO (1) CO5080778A1 (no)
HU (1) HUP0102516A2 (no)
ID (1) ID27574A (no)
IL (1) IL138387A0 (no)
NO (1) NO20004550L (no)
PE (1) PE20000345A1 (no)
PL (1) PL364704A1 (no)
SK (1) SK13652000A3 (no)
WO (1) WO1999046316A2 (no)
ZA (1) ZA991975B (no)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772455B1 (en) * 1997-11-14 2010-08-10 The Procter & Gamble Company Disposable article providing improved management of bodily exudates
US6291514B1 (en) 1998-02-09 2001-09-18 3-Dimensional Pharmaceuticals, Inc. Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
US6703536B2 (en) 1998-03-12 2004-03-09 The Procter & Gamble Company Disposable absorbent article having a skin care composition containing an enzyme inhibitor
ATE239512T1 (de) * 1998-03-12 2003-05-15 Procter & Gamble Protease-inhibitoren für absorbierende artikel
CO5111023A1 (es) 1998-12-31 2001-12-26 Kimberly Clark Co Composicion de articulo absorbente y metodo para usarla para secuestrar irritantes de la piel
US6479150B1 (en) 1999-02-26 2002-11-12 Kimberly-Clark Worldwide, Inc. Layer materials treated with surfactant-modified hydrophobic odor control agents
US6509284B1 (en) 1999-02-26 2003-01-21 Kimberly-Clark Worldwide, Inc. Layer materials treated with surfacant-modified chelating agents
US6433243B1 (en) 1999-02-26 2002-08-13 Kimberly-Clark Worldwide, Inc. Water permeable porous layer materials treated with surfactant-modified cyclodextrins
AU4858300A (en) * 1999-05-21 2000-12-12 Procter & Gamble Company, The Absorbent article having a skin care composition
EP1212097B1 (en) * 1999-09-10 2005-11-16 The Procter & Gamble Company Enzyme inhibitors
JP2003508480A (ja) * 1999-09-10 2003-03-04 ザ、プロクター、エンド、ギャンブル、カンパニー 酵素インヒビター
EP1212098A2 (en) * 1999-09-10 2002-06-12 The Procter & Gamble Company Enzyme inhibitors
US6503761B1 (en) * 1999-10-19 2003-01-07 Kimberly-Clark Worldwide, Inc. Selective removal of contaminants from a surface using articles having magnets
US6841393B2 (en) 1999-10-19 2005-01-11 Kimberly-Clark Worldwide, Inc. Selective removal of contaminants from a surface using colored particles and articles having magnets
US6464994B1 (en) * 2000-01-19 2002-10-15 Mentis Technologies, L.C. Diaper dermatitis preventative medication and a method for making and using same
US6376514B1 (en) 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6746418B1 (en) * 2000-11-17 2004-06-08 Playtex Products, Inc. Methods of lubricating a tampon and a tampon lubricated thereby
US7771735B2 (en) 2000-12-22 2010-08-10 Kimberly-Clark Worldwide, Inc. Absorbent articles with compositions for reducing irritation response
US20030022203A1 (en) * 2001-04-23 2003-01-30 Rajan Kumar Cellular Arrays
US7005557B2 (en) 2001-07-03 2006-02-28 The Procter & Gamble Company Film-forming compositions for protecting skin from body fluids and articles made therefrom
US6767553B2 (en) 2001-12-18 2004-07-27 Kimberly-Clark Worldwide, Inc. Natural fibers treated with acidic odor control/binder systems
US6852904B2 (en) 2001-12-18 2005-02-08 Kimberly-Clark Worldwide, Inc. Cellulose fibers treated with acidic odor control agents
US6805875B2 (en) * 2002-02-19 2004-10-19 Jennifer F. Bartels Composition and method for treating diaper rashes and skin irritations caused by acidic secretions
AU2003299568B2 (en) 2002-11-27 2010-07-22 Ampio Pharmaceuticals, Inc. Treatment of diseases and conditions mediated by increased phosphorylation
US7087559B2 (en) * 2002-12-16 2006-08-08 Avon Products, Inc. Non-foaming cleaning and conditioning hair care compositions
US20040122389A1 (en) * 2002-12-23 2004-06-24 Mace Tamara Lee Use of hygroscopic treatments to enhance dryness in an absorbent article
US20050192348A1 (en) * 2003-09-25 2005-09-01 David Bar-Or Methods and products which utilize N-acyl-L-aspartic acid
US20060029567A1 (en) 2004-08-04 2006-02-09 Bki Holding Corporation Material for odor control
US7265257B2 (en) * 2004-08-10 2007-09-04 Kimberly-Clark Worldwide, Inc. Absorbent articles comprising a bodily exudate modifying agent and a film-forming skin care formulation
US7642397B2 (en) * 2004-08-10 2010-01-05 Kimberly-Clark Worldwide, Inc. Absorbent articles comprising a bodily exudate modifying agent and a skin care formulation
US20060246383A1 (en) * 2005-04-29 2006-11-02 Kai-Kong Iu Amphoteric stilbene composition
US10265434B2 (en) 2016-09-29 2019-04-23 The Procter & Gamble Company Absorbent articles comprising glyceride copolymers
US12599657B2 (en) 2020-07-02 2026-04-14 Zivo Bioscience, Inc. Enhancement of vaccine efficacy via biomass and/or related material in animal drink and feed

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
FR2252351A2 (en) * 1973-11-28 1975-06-20 Air Liquide Isolation of enzymes by selective extraction - partition of polyinhibitor-enzyme complex between water and polyethylene glycol
GB1472700A (en) * 1974-11-01 1977-05-04 Ono Pharmaceutical Co Guanidinobehzoic acid derivatives and process for preparing the same
JPS5470241A (en) * 1977-11-09 1979-06-05 Ono Pharmaceut Co Ltd Guanidinobenzoic acid derivative and its preparation
JPS5634662A (en) * 1979-08-31 1981-04-06 Ono Pharmaceut Co Ltd Guanidinobenzoic acid derivative and its preparation
AU527371B2 (en) * 1980-09-16 1983-03-03 Torii & Co., Ltd. Amidine
DE3207033C2 (de) * 1981-02-27 1984-09-13 Torii & Co., Ltd., Tokyo Amidinverbindungen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
US4556560A (en) * 1983-01-24 1985-12-03 The Procter & Gamble Company Methods for the treatment and prophylaxis of diaper rash and diaper dermatitis
GB8500209D0 (en) * 1985-01-04 1985-02-13 Ceskoslovenska Akademie Ved Synthetic polymeric drugs
CS254355B1 (en) * 1985-04-10 1988-01-15 Vladimir Saudek Soluble and biodegradatable copolymeres activated for bond of biologicaly active substances
PH26954A (en) 1985-05-15 1992-12-03 Procter & Gamble Disposable absorbent articles
US4657537A (en) 1985-05-15 1987-04-14 The Procter & Gamble Company Disposable absorbent articles
US4746737A (en) * 1985-07-26 1988-05-24 Kowa Co., Ltd. Phenyl guanidinobenzoate derivatives which have protease inhibitory activity
US5247084A (en) * 1985-11-12 1993-09-21 Ono Pharmaceutical Co., Ltd. Derivatives of p-guanidinobenzoic acid
JPH0676373B2 (ja) * 1985-12-27 1994-09-28 エーザイ株式会社 グアニジノ安息香酸エステル誘導体
US4873253A (en) * 1987-03-30 1989-10-10 Shosuke Okamoto Phenylalanine derivative and proteinase inhibitor
US4842593A (en) 1987-10-09 1989-06-27 The Procter & Gamble Company Disposable absorbent articles for incontinent individuals
US4948891A (en) * 1988-05-24 1990-08-14 Pfizer Inc. Benzamide protease inhibitors
US5162307A (en) * 1988-09-09 1992-11-10 Board Of Trustees Of The University Of Kentucky Polymer bound elastase inhibitors
FR2651125B1 (fr) * 1989-08-23 1992-10-02 Roussel Uclaf Compositions pharmaceutiques de type "pates a l'eau".
CA2032420A1 (en) * 1989-12-22 1991-06-23 Akira Okuyama Guanidinobenzene derivatives
DK0435235T3 (da) * 1989-12-28 1995-05-22 Snow Brand Milk Products Co Ltd Nye isoquinolinderivater og salte deraf
DE69120141T2 (de) * 1990-03-28 1996-11-28 Shuji Kojima Polymerkombiniertes Arzneimittel zur Magenbehandlung und Verfahren zu dessen Herstellung
US5660822A (en) * 1990-05-14 1997-08-26 University Of Medicine & Dentistry Of N.J. Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5372807A (en) * 1990-05-14 1994-12-13 University Of Medicine And Dentistry Of New Jersey Polymers containing antifibrotic agents, compositions containing such polymers, and methods of preparation and use
JPH0446148A (ja) * 1990-06-08 1992-02-17 Asahi Chem Ind Co Ltd ４―グアニジノ安息香酸フェニルエステル誘導体およびそれらを含有する蛋白分解酵素阻害剤
JP3051145B2 (ja) * 1990-08-28 2000-06-12 住友製薬株式会社 新規なポリエチレングリコール誘導体修飾ペプチド
IT1260468B (it) * 1992-01-29 1996-04-09 Metodo per mantenere l'attivita' di enzimi proteolitici modificati con polietilenglicole
AU4406793A (en) * 1992-06-04 1993-12-30 Clover Consolidated, Limited Water-soluble polymeric carriers for drug delivery
ZA933926B (en) * 1992-06-17 1994-01-03 Amgen Inc Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules
CA2101361A1 (en) * 1992-08-27 1994-02-28 Robert A. Snow Low diol polyalkylene oxide biologically active proteinaceous substances
US5432178A (en) * 1992-09-18 1995-07-11 Ono Pharmaceutical Co., Ltd. Amidinophenol derivatives
EP0673924A4 (en) * 1992-12-10 1996-04-24 Teikoku Chem Ind Co Ltd PROPRIONIC ACID DERIVATIVE.
US5449720A (en) * 1993-05-24 1995-09-12 Biotech Australia Pty Limited Amplification of the VB12 uptake system using polymers
US5840485A (en) * 1993-05-27 1998-11-24 Selectide Corporation Topologically segregated, encoded solid phase libraries
WO1994028024A1 (en) * 1993-06-01 1994-12-08 Enzon, Inc. Carbohydrate-modified polymer conjugates with erythropoietic activity
GB9317618D0 (en) * 1993-08-24 1993-10-06 Royal Free Hosp School Med Polymer modifications
US5643575A (en) * 1993-10-27 1997-07-01 Enzon, Inc. Non-antigenic branched polymer conjugates
US5446090A (en) * 1993-11-12 1995-08-29 Shearwater Polymers, Inc. Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules
DE4342154A1 (de) * 1993-12-10 1995-06-14 Behringwerke Ag Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien
TW300883B (no) * 1994-07-26 1997-03-21 Kao Corp
US5783178A (en) * 1994-11-18 1998-07-21 Supratek Pharma. Inc. Polymer linked biological agents
GB9600272D0 (en) * 1996-01-06 1996-03-06 Univ Nottingham Polymers
US5869033A (en) * 1996-04-12 1999-02-09 Enviroderm Pharmaceuticals,Inc. Method of preventing skin irritation caused by fecal enzymes

Also Published As

Publication number Publication date
KR20010041860A (ko) 2001-05-25
PE20000345A1 (es) 2000-05-16
ID27574A (id) 2001-04-12
ZA991975B (en) 1999-09-27
BR9909248A (pt) 2001-10-09
IL138387A0 (en) 2001-10-31
PL364704A1 (en) 2004-12-13
WO1999046316A3 (en) 2000-03-23
CA2323496A1 (en) 1999-09-16
HUP0102516A2 (hu) 2001-11-28
US6211186B1 (en) 2001-04-03
EP1062264A2 (en) 2000-12-27
JP2002506099A (ja) 2002-02-26
SK13652000A3 (sk) 2001-04-09
US6066673A (en) 2000-05-23
NO20004550D0 (no) 2000-09-12
CO5080778A1 (es) 2001-09-25
WO1999046316A2 (en) 1999-09-16
AU2903799A (en) 1999-09-27
CN1300303A (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
WO1999046316A3 (en) Enzyme inhibitors
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
NO20052888L (no) Diamintriazoler anvendelige som inhibitorer av proteinkinaser
SE0101387D0 (sv) Novel compounds
DE10393306D2 (de) Mesenchymale Stammzellen des Haarfollikels und deren Verwendung
AU2002258066A1 (en) Dermatological and cosmetic compositions
TW200512007A (en) Cosmetic compositions containing fullerene clusters
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
NO20054848L (no) Substituerte p-diaminobenzenderivater
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
CY1111070T1 (el) Παραγωγα 2-αμινο-κουιναζολινης χρησιμα ως αναστολεις της β-σεκρετασης (bace)
AR043918A1 (es) Reduccion del crecimiento del vello utilizando una composicion que contiene difluorometilornitina
SE0302756D0 (sv) Novel Compounds
NO20052698L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gasatrintestinale lidelser.
DE50310486D1 (de) Lipid-transferprotein - systeme und deren kosmetische dermatologische anwendung
NO20075433L (no) Harvann
BR0211784A (pt) Método para reduzir o crescimento capilar humano, uso de alfa-difluorometilornitina, e composição cosmética usada para a redução do crescimento capilar humano
NO20052699L (no) 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser.
AU5326098A (en) Benzofuranacrylic acid derivatives and their use as modulators of RXRS or RARS receptors
ATE400552T1 (de) 4,4' -dithiobis- (3-aminobutane-1-sulfonate)- derivate und sie enthaltende zusammensetzungen
AU2003226709A1 (en) Organosilicone derivatives of amino hydroxybenzophenones and their use as uv-a filters in cosmetic preparations
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
NO20063619L (no) Diarylmetylpiperazinderivater, fremstilling og anvendelse derav
ATE419825T1 (de) Partikuläre farbzusammensetzung und ihre anwendung in körperpflegeprodukten
ATE387422T1 (de) Ceramides, zusammensetzungen die diese enthalten und ihre verwendunge

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application